Blog
The signal for cancer often exists years before the diagnosis. We simply have not been able to see it.
Introducing Truveta Intelligence: Insights from real-world care in minutes, not months
CDC study links later clinic visits to lower antihypertensive adherence
Predicting early-onset colorectal cancer with large language models
GLP-1 RA prescription trends: January 2019 – March 2026
AMCP 2026: Impact of the CVS GLP-1 formulary change
AMCP 2026: Real-world adherence and MRI monitoring patterns among patients treated with lecanemab in the United States
